Schedule 13G ownership disclosure
Arcutis Biotherapeutics Inc
Security class unavailable · CUSIP: 03969K108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,880,402
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001306550-23-010278
- Form type
- SC 13G
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- Nov 07, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership